-
FPH1: Building a Function-First Liver Platform
2026-09-29
FPH1 (BRD-6125) reframes hepatocyte expansion around function, not cell number alone. This thought-leadership article connects functional proliferation assays and iPSC-derived hepatocyte workflows with emerging, light-regulated gene therapy while clearly separating established evidence from future translational opportunities.
-
Transient P1 Unwinding in Adenine Riboswitch Binding
2026-09-29
Wu et al. combined position-selective RNA labeling with stopped-flow fluorescence to resolve ligand-dependent conformational kinetics in the full-length adenine riboswitch. The study identifies a short-lived unwound P1 state and shows that P1 responds before the binding pocket and P4, separating early ligand recognition from later structural stabilization.
-
Carbapenemase Gene Transmission in CREC
2026-09-28
Chen et al. examined carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining gene detection, plasmid-transfer experiments, susceptibility testing, and strain fingerprinting. The study shows that blaNDM-1 was frequently plasmid-associated and transferable, supporting a surveillance strategy that evaluates resistance genes, mobile elements, phenotype, and clonality together.
-
Farnesylation-Driven KRAS Condensates in Colon Cancer
2026-09-28
The study proposes that farnesylation at KRAS C185 promotes cytoplasmic condensates that cluster RCE1, support KRAS processing and membrane localization, and amplify tumor-promoting signaling in colon cancer. It also reports that statins, particularly pitavastatin, disrupt this process and can improve response to KRAS G12C inhibition, suggesting a combination strategy that merits further validation.
-
Lassa Virus Spike: pH-Driven Entry and Inhibitor Action
2026-09-27
Katz and colleagues map pH-induced structural changes in the Lassa virus spike that help explain receptor release and preparation for membrane fusion. Their structural and functional analysis also shows how ARN-75039 inhibits viral entry, providing a mechanistic basis for further study of this investigational inhibitor.
-
Etoposide (VP-16): Separating DNA Damage from Senescence
2026-09-26
Etoposide (VP-16) is a powerful DNA-damaging research tool, but its effects can be mistaken for senescence or senolysis if assay endpoints are not separated. This guide connects its topoisomerase II mechanism with a Lactobacillus-derived nanovesicle study to show how to design more interpretable experiments.
-
Açaí Extracts: Hepatocyte Toxicity and DDI Potential
2026-09-25
Raichura and colleagues compared solvent-specific açaí extracts in human hepatocytes and complementary transporter assays, finding extract-dependent, time- and dose-related cytotoxicity but no significant induction of the tested CYP enzymes or transporters. The work highlights why botanical–drug interaction assessment should distinguish cell injury, gene-expression changes, and transporter function rather than treating them as interchangeable measures.
-
Cholecystokinin octapeptide ammonium in assays
2026-09-25
A practical, evidence-aware guide to using Cholecystokinin octapeptide ammonium (SKU C8717) in cell-response experiments. It covers receptor context, formulation constraints, concentration planning, interpretation of atrial ANP findings, and criteria for selecting a research reagent.
-
From PXDN to LDHA: Testing GBM Metabolism
2026-09-24
A translational framework for probing the PXDN–LDHA glycolysis axis in glioblastoma, with practical guidance on nucleic-acid perturbation, rescue experiments, and choosing a low-toxicity lipid transfection reagent.
-
Poly(I:C): TLR3 Agonist for Innate Immunity
2026-09-24
Poly (I:C) is a synthetic double-stranded RNA analog used to stimulate innate immune signaling and interferon responses. Its effects depend on the cell model and delivery route, so it is a research stimulus—not a substitute for viral infection or a universal immune-activation protocol.
-
CD40–STING–TRAF2 Signaling in ESCC TLS
2026-09-23
A 2025 study links tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma with favorable survival and identifies IRF4-high B cells as a prominent immune feature. Its mechanistic experiments propose that CD40 and STING compete for TRAF2, connecting non-canonical NF-κB signaling with B-cell activation and providing testable directions for biomarker and cancer immunotherapy research.
-
ICG001: Precision Control of Wnt/β-Catenin
2026-09-23
Explore how ICG001, a selective Wnt/β-catenin pathway inhibitor, separates CBP-dependent transcription from upstream pathway activation. This article translates recent exosome-mediated osteogenesis findings into a practical framework for cancer, fibrosis, and mechanistic Wnt assays.
-
Cy3 Goat Anti-Rabbit IgG: Evidence-Led Imaging
2026-09-22
Discover how the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody supports rigorous fluorescence detection beyond routine staining. This evidence-led guide connects reagent architecture with interpretation of Wnt/β-catenin findings in ulcerative colitis research.
-
Arginine Methylation, FUS–SMN, and Neuronal Granules
2026-09-22
Wang and Li show that asymmetric dimethylation of FUS creates binding sites for oligomeric SMN, promoting multivalent interactions that lower the threshold for phase separation and neuronal granule assembly. The study links this mechanism to axonal mRNA distribution and demonstrates that restoring SMN valency can alleviate selected neuronal defects associated with SMN depletion.
-
IL-2, Human Recombinant: Assay Design Guide
2026-09-21
Learn how IL-2, human recombinant can support controlled immune-cell assays while a recent FUS–SMN study reveals broader principles for interpreting multivalent protein assemblies. This guide translates that insight into practical stimulation, control, and readout decisions.